VZV immune globulin VZV immune globulin VZV (varicella zoster virus) globulin or VZV antibodies is an immune system medication that is used mostly for immunosuppressed patients who have been or may be exposed to the varicella zoster virus. It shortens the course of cutaneous disease and may protect against its dissemination. Varicella zoster virus is a human herpes virus that causes chickenpox, shingles, Ramsay Hunt syndrome type II, and postherpetic neuralgia. Unlike a Zoster vaccine which provides durable immunity, the protection is passive and short term; it may need to be readministered every 2-4 weeks as necessary. This medication is not recommended for
European Centre for Disease Prevention and Control The office of the Chief Scientist oversees the seven Disease Programmes, the Microbiology Coordination Section and the Scientific Advice Coordination Section. The Disease Programmes focus on specific disease groups: Two shared-resource units – Surveillance and Response Support, and Public Health Capacity and Communication – provide specialist expertise. The Information and Communication Technologies Unit provides infrastructure, application development and support. The Resource Management and Coordination Unit controls ECDC’s human and financial resources. ECDC publishes numerous scientific and technical reports covering various issues related to the prevention and control of communicable diseases. Comprehensive reports from key technical and scientific meetings are also